JM

John M. McCall

TU The Upjohn: 32 patents #4 of 528Top 1%
BI Bioenergenix: 15 patents #1 of 7Top 15%
RB Reveragen Biopharma: 14 patents #1 of 6Top 20%
IB Imago Biosciences: 9 patents #3 of 14Top 25%
VE Vesture: 6 patents #17 of 204Top 9%
PC Pharmacia & Upjohn Company: 3 patents #145 of 713Top 25%
CT Cadent Therapeutics: 1 patents #15 of 23Top 70%
KB Knopp Biosciences: 1 patents #21 of 33Top 65%
KN Knopp Neurosciences: 1 patents #4 of 8Top 50%
AR Albany Molecular Research: 1 patents #71 of 122Top 60%
PH Pharmacia: 1 patents #257 of 528Top 50%
Overall (All Time): #16,201 of 4,157,543Top 1%
94
Patents All Time

Issued Patents All Time

Showing 25 most recent of 94 patents

Patent #TitleCo-InventorsDate
12201639 Aqueous oral pharmaceutical suspension compositions Jesse DAMSKER 2025-01-21
12187682 MCT4 inhibitors for treating disease Kenneth Mark Parnell 2025-01-07
11833159 Non-hormonal steroid modulators of NF-kB for treatment of disease Eric Hoffman, Kanneboyina Nagaraju 2023-12-05
11773068 KDM1A inhibitors for the treatment of disease Hugh Y. Rienhoff, Jr., Michael Clare, Cassandra Celatka, Amy E. Tapper 2023-10-03
11771684 Inhibitors of dihydroceramide desaturase for treating disease Donna L. Romero, Jeremy Blitzer 2023-10-03
11724989 MCT4 inhibitors for treating disease Kenneth Mark Parnell 2023-08-15
11690853 Non-hormonal steroid modulators of NF-κβ for treatment of disease Eric Hoffman, Kanneboyina Nagaraju, Jesse DAMSKER 2023-07-04
11661409 Acid addition salts, compositions, and methods of treating Harris A. Gelbard, Jesse DAMSKER, Arthur Glenn Romero 2023-05-30
11655226 KDM1A inhibitors for the treatment of disease Hugh Y. Rienhoff, Jr., Michael Clare 2023-05-23
11479541 Acid addition salts, compositions, and methods of treating thereof Harris A. Gelbard, Jesse DAMSKER, Arthur Glenn Romero 2022-10-25
11471471 Aqueous oral pharmaceutical suspension compositions Jesse DAMSKER 2022-10-18
11459307 Heterocyclic compounds for the inhibition of PASK Donna L. Romero, John McKearn, Michael Clare 2022-10-04
11390590 Methods and processes for the preparation of KDM1A inhibitors Amy E. Tapper, Cassandra Celatka, Arthur Glenn Romero, Toni Chancellor, Jian-Xie Chen +6 more 2022-07-19
11382922 Aqueous oral pharmaceutical suspension compositions Jesse DAMSKER 2022-07-12
11292767 Heterocyclic inhibitors of MCT4 Kenneth Mark Parnell, Donna L. Romero 2022-04-05
11230534 KDM1A inhibitors for the treatment of disease Hugh Y. Rienhoff, Jr., Michael Clare, Cassandra Celatka, Amy E. Tapper 2022-01-25
11191765 Heterocyclic compounds for the inhibition of PASK Robert C. Kelly, Donna L. Romero 2021-12-07
11155522 MCT4 inhibitors for treating disease Kenneth Mark Parnell 2021-10-26
11135207 Inhibitors of dihydroceramide desaturase for treating disease Donna L. Romero, Jeremy Blitzer 2021-10-05
10953012 Heterocyclic compounds for the inhibition of pask Robert C. Kelly, Donna L. Romero 2021-03-23
10882835 KDM1A inhibitors for the treatment of disease Hugh Y. Rienhoff, Jr., Michael Clare 2021-01-05
10857161 Non-hormonal steroid modulators of NF-kB for treatment of disease Eric Hoffman, Kanneboyina Nagaraju 2020-12-08
10799514 Non-hormonal steroid modulators of NF-kappa beta for treatment of disease Eric Hoffman, Kanneboyina Nagaraju, Jesse DAMSKER 2020-10-13
10781185 Heterocyclic compounds for the inhibition of PASK Donna L. Romero, John McKearn, Michael Clare 2020-09-22
10774064 Potassium channel modulators Birgitte L. Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson +6 more 2020-09-15